EP3041828
Afleiður af 1,3,4-oxadíasól og 1,3,4-þíadíasól sem ónæmistemprandi lyf
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
5.9.2014EP published:
23.5.2018EP application number:
14842822.0
EP translation filed:
20.8.2018Grant published:
15.9.2018EPO information:
European Patent Register
Max expiry date:
4.9.2034Expiry date:
4.9.2019
Title:
1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE DERIVATIVES AS IMMUNOMODULATORS
Timeline
Today
5.9.2014EP application
23.5.2018EP Publication
20.8.2018Translation submitted
15.9.2018Registration published
4.9.2019Expires
Owner
Name:
Aurigene Discovery Technologies LimitedAddress:
39-40 KIADB Industrial Area Electronic City Phase-II Hosur Road, 560100, Bangalore, Karnataka, IN
Inventor
Name:
SASIKUMAR, Pottayil Govindan NairAddress:
Bangalore, IN
Name:
RAMACHANDRA, MuralidharaAddress:
Bangalore, IN
Name:
NAREMADDEPALLI, Seetharamaiah Setty SudarshanAddress:
Bangalore, IN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
4012CH2013Date:
6.9.2013Country:
IN
Classification
Categories:
C07D 271/06, C07D 285/08, A61K 31/4245, A61K 31/433, A61P 31/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 29.8.2018
Expires: 4.9.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.